Many mental illnesses arise in adolescence, and a study of national insurance claims in the United States finds a large variance in how adolescent patients are treated even within the same zip code. The findings, reported in Janet Currie’s Inaugural Article (IA) (1), reveal that 45% of adolescents receive first-line treatments that are not approved by the US Food and Drug Administration (FDA) (1). Currie, elected to the National Academy of Sciences in 2019, has studied children’s health for three decades. A professor of economics and public affairs at Princeton University, Currie has undertaken pioneering economic analysis of child development, including analysis of the effects of the Head Start program on children (2, 3) and the effects of expansions of the Medicaid program for pregnant women and children (4, 5). In her IA (1), Currie analyzes a large national dataset to reveal disparities in treatment that cannot be attributed to supply-side factors, such as limited availability of treatment providers.

中文翻译：

---

与Janet Currie的QnA。

青春期会出现许多精神疾病，而且对美国的国家保险索赔进行的研究发现，即使在相同的邮政编码范围内，治疗青少年患者的方式也存在很大差异。这一发现，在珍妮特·柯里的就职文章（IA）（报道1），揭示了青少年的45％接收不是由美国食品和药物管理局（FDA）（批准的第一线治疗1）。柯里，在2019年当选为美国国家科学院，研究了儿童的健康为三个十年。普林斯顿大学经济学和公共事务教授柯里先后承担孩子的发展开拓经济分析，包括对儿童的启蒙计划的影响分析（2，3），以及孕妇和儿童（医疗补助计划的扩展的效果4，5）。在她的IA（1）中，Currie分析了一个庞大的国家数据集，以揭示治疗差异，这些差异不能归因于供应方因素，例如治疗提供者的可获得性有限。